[1] Gottesman, M.M.; Fojo, T.; Bates, S.E. Nat. Rev. Cancer. 2002, 2, 48-58.
[2] Nobili, S.; Landini, I.; Mazzei, T. Med. Res. Rev. 2012, 32, 1220-1262.
[3] Ozben, T. FEBS Lett. 2006, 580, 2903-2909.
[4] Coley, H.M. Cancer Treat. Rev. 2008, 34, 378-390.
[5] Yu, M.; Ocana, A.; Tannock, I.F. Cancer Metastasis Rev. 2013, 32, 211-227.
[6] Callaghan, R.; Luk, F.; Bebawy, M. Drug Metab. Dispos. 2014, 42, 623-631.
[7] Zhang, W.; Han, Y.; Lim, S.L. Expert. Opin. Drug Metab. Toxicol. 2009, 5, 789-801.
[8] Bhardwaj, R.K.; Glaeser, H.; Becquemont, L. J. Pharmacol. Exp. Ther. 2002, 302, 645-650.
[9] Yoshida, N.; Takagi, A.; Kitazawa, H. J. Pharm. Sci. 2006, 95, 552-560.
[10] Yoshida, N.; Koizumi, M.; Adachi, I. Food Chem. Toxicol. 2006, 44, 2033-2039.
[11] Han, Y.; Chin Tan, T.M.; Lim, L. Toxicol. Appl. Pharm. 2008, 230, 283-289.
[12] Coley, H.M. Development of drug-resistant models, in Cancer Cell Culture (Langdon S.P. Ed.), Springer, Heidelberg, 2004, 267-273.
[13] Vichai, V.; Kirtikara, K. Nat. Protoc. 2006, 1, 1112-1116.
[14] Skehan, P.; Storeng, R.; Scudiero, D. J. Natl. Cancer Inst. 1990, 82, 1107-1112.
[15] Cowan, K.H.; Moscow, J.A.; Huang, H. Clin. Cancer Res. 1999, 5, 1619-1628.
[16] Kong, A.T.; Yu, S. J. Chin. Pharm. Sci. 2016, 25, 233-234.
[17] Han, Y.; Chin, T.T.; Lim, L.Y. Toxicol. Appl. Pharmacol. 2008, 230, 283-289.
[18] Doucette, C.D.; Hilchie, A.L.; Liwski, R. J. Nutr. Biochem. 2013, 24, 231-239. |